Apyx Medical Corporation (APYX) |
| 3.82 -0.06 (-1.55%) 04-14 12:58 |
| Open: | 3.92 |
| High: | 3.995 |
| Low: | 3.76 |
| Volume: | 138,795 |
| Market Cap: | 160(M) |
| PE Ratio: | -14.15 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 4.88 |
| Resistance 1: | 4.18 |
| Pivot price: | 3.79 |
| Support 1: | 3.67 |
| Support 2: | 3.35 |
| 52w High: | 4.5 |
| 52w Low: | 0.825 |
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| EPS | -0.270 |
| Book Value | 0.350 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.790 |
| Profit Margin (%) | -21.22 |
| Operating Margin (%) | 0.06 |
| Return on Assets (ttm) | -6.1 |
| Return on Equity (ttm) | -76.2 |
Mon, 06 Apr 2026
Why The Apyx Medical (APYX) Story Is Shifting With New Guidance And GLP-1 Demand - Yahoo Finance
Wed, 01 Apr 2026
Renuvion wins NewBeauty again, extending its skin-tightening streak - Stock Titan
Sat, 21 Mar 2026
If You Invested $1,000 in Apyx Medical Corporation (APYX) - Stock Titan
Tue, 10 Mar 2026
Apyx Medical (APYX) Q4 Revenue Jumps 34.8% to $19.2M, Loss Narrows to $0.06/Share - AlphaStreet
Tue, 10 Mar 2026
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire
Wed, 25 Feb 2026
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026 - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |